Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting.

Da Ros A, Peloso A, Longo G, Benetton M, Indio V, Cairo S, Sandri M, Buldini B, Bresolin S, Rosato A, Pession A, Tregnago C, Locatelli F, Pigazzi M.

Open source

DOI: 10.1182/bloodadvances.2025018002
Published: 2026-04-01
Container: Blood Adv
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025018002,
  title = {Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting.},
  author = {Da Ros A and  Peloso A and  Longo G and  Benetton M and  Indio V and  Cairo S and  Sandri M and  Buldini B and  Bresolin S and  Rosato A and  Pession A and  Tregnago C and  Locatelli F and  Pigazzi M.},
  year = {2026},
  journal = {Blood Adv},
  doi = {10.1182/bloodadvances.2025018002},
  url = {https://doi.org/10.1182/bloodadvances.2025018002}
}

RIS

TY  - JOUR
TI  - Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting.
AU  - Da Ros A
AU  -  Peloso A
AU  -  Longo G
AU  -  Benetton M
AU  -  Indio V
AU  -  Cairo S
AU  -  Sandri M
AU  -  Buldini B
AU  -  Bresolin S
AU  -  Rosato A
AU  -  Pession A
AU  -  Tregnago C
AU  -  Locatelli F
AU  -  Pigazzi M.
PY  - 2026
JO  - Blood Adv
DO  - 10.1182/bloodadvances.2025018002
UR  - https://doi.org/10.1182/bloodadvances.2025018002
ER  -

APA

A, D. R., A, P., G, L., M, B., V, I., S, C., M, S., B, B., S, B., A, R., A, P., C, T., F, L., & M., P. (2026). Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting.. Blood Adv. https://doi.org/10.1182/bloodadvances.2025018002

Source records

europe-pmc · retrieved 2026-09-26T20:21:25.993Z